Literature DB >> 28619398

Global Burden of Disease of Mercury Used in Artisanal Small-Scale Gold Mining.

Nadine Steckling1, Myriam Tobollik2, Dietrich Plass3, Claudia Hornberg4, Bret Ericson5, Richard Fuller5, Stephan Bose-O'Reilly6.   

Abstract

BACKGROUND: Artisanal small-scale gold mining (ASGM) is the world's largest anthropogenic source of mercury emission. Gold miners are highly exposed to metallic mercury and suffer occupational mercury intoxication. The global disease burden as a result of this exposure is largely unknown because the informal character of ASGM restricts the availability of reliable data.
OBJECTIVE: To estimate the prevalence of occupational mercury intoxication and the disability-adjusted life years (DALYs) attributable to chronic metallic mercury vapor intoxication (CMMVI) among ASGM gold miners globally and in selected countries.
METHODS: Estimates of the number of artisanal small-scale gold (ASG) miners were extracted from reviews supplemented by a literature search. Prevalence of moderate CMMVI among miners was determined by compiling a dataset of available studies that assessed frequency of intoxication in gold miners using a standardized diagnostic tool and biomonitoring data on mercury in urine. Severe cases of CMMVI were not included because it was assumed that these persons can no longer be employed as miners. Cases in workers' families and communities were not considered. Years lived with disability as a result of CMMVI among ASG miners were quantified by multiplying the number of prevalent cases of CMMVI by the appropriate disability weight. No deaths are expected to result from CMMVI and therefore years of life lost were not calculated. Disease burden was calculated by multiplying the prevalence rate with the number of miners for each country and the disability weight. Sensitivity analyses were performed using different assumptions on the number of miners and the intoxication prevalence rate.
FINDINGS: Globally, 14-19 million workers are employed as ASG miners. Based on human biomonitoring data, between 25% and 33% of these miners-3.3-6.5 million miners globally-suffer from moderate CMMVI. The resulting global burden of disease is estimated to range from 1.22 (uncertainty interval [UI] 0.87-1.61) to 2.39 (UI 1.69-3.14) million DALYs.
CONCLUSIONS: This study presents the first global and country-based estimates of disease burden caused by mercury intoxication in ASGM. Data availability and quality limit the results, and the total disease burden is likely undercounted. Despite these limitations, the data clearly indicate that mercury intoxication in ASG miners is a major, largely neglected global health problem.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DALY; artisanal small-scale gold mining; burden of disease; disability-adjusted life year; global; mercury; mercury intoxication

Mesh:

Substances:

Year:  2017        PMID: 28619398     DOI: 10.1016/j.aogh.2016.12.005

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  26 in total

1.  Total blood mercury and its determinants in New Zealand children and adults.

Authors:  Andrea 't Mannetje; Jonathan Coakley; Jeroen Douwes
Journal:  J Expo Sci Environ Epidemiol       Date:  2021-02-18       Impact factor: 5.563

2.  Mercury Exposure in Artisanal Mining: Assessing the Effect of Occupational Activities on Blood Mercury Levels Among Artisanal and Small-Scale Goldminers in Ghana.

Authors:  Benjamin M Saalidong; Simon Appah Aram
Journal:  Biol Trace Elem Res       Date:  2021-11-13       Impact factor: 4.081

Review 3.  The Mercury Problem in Artisanal and Small-Scale Gold Mining.

Authors:  Louisa J Esdaile; Justin M Chalker
Journal:  Chemistry       Date:  2018-02-05       Impact factor: 5.236

4.  Comparing the self-reported health-related quality of life (HRQoL) of artisanal and small-scale gold miners and the urban population in Zimbabwe using the EuroQol (EQ-5D-3L+C) questionnaire: a cross-sectional study.

Authors:  Jana Becker; Stephan Bose-O'Reilly; Dennis Shoko; Josephine Singo; Nadine Steckling-Muschack
Journal:  Health Qual Life Outcomes       Date:  2020-07-29       Impact factor: 3.186

5.  Lung Function Assessment as an Early Biomonitor of Mercury-Induced Health Disorders in Artisanal and Small-Scale Gold Mining Areas in Indonesia.

Authors:  Sri Manovita Pateda; Masayuki Sakakibara; Koichiro Sera
Journal:  Int J Environ Res Public Health       Date:  2018-11-07       Impact factor: 3.390

6.  Pollution and Global Health – An Agenda for Prevention.

Authors:  Philip J Landrigan; Richard Fuller; Howard Hu; Jack Caravanos; Maureen L Cropper; David Hanrahan; Karti Sandilya; Thomas C Chiles; Pushpam Kumar; William A Suk
Journal:  Environ Health Perspect       Date:  2018-08-06       Impact factor: 9.031

7.  Repeated Exposition to Mercury (II) Chloride Enhances Susceptibility to S. schenckii sensu stricto Infection in Mice.

Authors:  Alexander Batista-Duharte; Damiana Téllez-Martínez; Juliana Aparecida Jellmayer; Deivys Leandro Portuondo Fuentes; Marisa Campos Polesi; Amanda Martins Baviera; Iracilda Zeppone Carlos
Journal:  J Fungi (Basel)       Date:  2018-05-25

Review 8.  Sex-specific neurotoxic effects of heavy metal pollutants: Epidemiological, experimental evidence and candidate mechanisms.

Authors:  Meethila Gade; Nicole Comfort; Diane B Re
Journal:  Environ Res       Date:  2021-07-02       Impact factor: 8.431

9.  Applying methods of the global burden of diseases, injuries, and risk factors study to developmental neurotoxicants: a commentary.

Authors:  David C Bellinger
Journal:  Environ Health       Date:  2018-06-04       Impact factor: 5.984

10.  Health-related quality of life (EQ-5D + C) among people living in artisanal and small-scale gold mining areas in Zimbabwe: a cross-sectional study.

Authors:  Friederike-Marie Butscher; Stefan Rakete; Myriam Tobollik; Viola Mambrey; Dingani Moyo; Dennis Shoko; Shamiso Muteti-Fana; Nadine Steckling-Muschack; Stephan Bose-O'Reilly
Journal:  Health Qual Life Outcomes       Date:  2020-08-18       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.